Bionomics Limited (NASDAQ: BNOX)
$0.2346
-0.0155 ( -6.53% ) 413.4K
Bionomics Ltd is a global, clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.
Market Data
Open
$0.2346
Previous close
$0.2501
Volume
413.4K
Market cap
$4.97M
Day range
$0.2300 - $0.2720
52 week range
$0.1770 - $1.6000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Jul 16, 2024 |
3 | Insider transactions | 1 | Jul 12, 2024 |
3 | Insider transactions | 1 | Jul 08, 2024 |
3 | Insider transactions | 1 | Jul 08, 2024 |
3 | Insider transactions | 1 | Jul 08, 2024 |
3 | Insider transactions | 1 | Jul 08, 2024 |
3 | Insider transactions | 1 | Jul 08, 2024 |
3 | Insider transactions | 1 | Jul 08, 2024 |
6-k | Form 6-K | 6 | Jun 03, 2024 |
6-k | Form 6-K | 9 | Mar 15, 2024 |